TNF-α-mediated reduction in PGC-1α may impair skeletal muscle function after cigarette smoke exposure

Journal of Cellular Physiology

Volumn 222, Issue 2, 2010, Pages 320-327

  Tang, Kechun ^a   Wagner, Peter D ^a   Breen, Ellen C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ATROGIN 1; CIGARETTE SMOKE; CITRATE SYNTHASE; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN; FBXO32 PROTEIN, MOUSE; MUSCLE PROTEIN; PPARGC1A PROTEIN, MOUSE; RNF30 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY MASS; CAPILLARY; CIGARETTE SMOKING; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXERCISE; GASTROCNEMIUS MUSCLE; GENE TARGETING; GLYCOLYSIS; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE FATIGUE; MYOBLAST; NONHUMAN; OXIDATION; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SOLEUS MUSCLE; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; EXERCISE TOLERANCE; EXPOSURE; FAST MUSCLE FIBER; GENETICS; HINDLIMB; METABOLISM; MUSCLE CONTRACTION; OXIDATION REDUCTION REACTION; PASSIVE SMOKING; PATHOLOGY; PATHOPHYSIOLOGY; SLOW MUSCLE FIBER; SMOKING; TIME; VASCULARIZATION;

MUS;

ANIMALS; CAPILLARIES; CELL LINE; DOWN-REGULATION; EXERCISE TOLERANCE; GLYCOLYSIS; HINDLIMB; INHALATION EXPOSURE; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; OXIDATION-REDUCTION; RNA, MESSENGER; SKP CULLIN F-BOX PROTEIN LIGASES; SMOKING; TIME FACTORS; TOBACCO SMOKE POLLUTION; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73349101897     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21955     Document Type: Article

References (37)

1. Adhihetty PJ, Uguccioni G, Leick L, Hidalgo J, Pilegaard H, Hood DA. 2009. The role of PGC-1{alpha} on mitochondrial function and apoptotic susceptibility in muscle. Am J Physiol Cell Physiol 297: C217-C225.
2. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. 2005. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1:259-271.
3. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM. 2008. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451:1008-1012.
4. Attaix D, Combaret L, Bechet D, Taillandier D. 2008. Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia. Curr Opin Support Palliat Care 2:262-266.
5. Barnes PJ. 2003. New concepts in chronic obstructive pulmonary disease. Annu Rev Med 54:113-129.
6. Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J. 2008. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63:100-107.
7. Bergmeyer H. 1974. Methods in enzymatic analysis. New York: Academic. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD. 1996. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81:355-361.
8. Chen H, Hansen MJ, Jones JE, Vlahos R, Bozinovski S, Anderson GP, Morris MJ. 2006. Cigarette smoke exposure reprograms the hypothalamic neuropeptide Y axis to promote weight loss. Am J Respir Crit Care Med 173:1248-1254.
9. Del Prete Z, Musaro A, Rizzuto E. 2008. Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf-1 transgenic skeletal muscle. Ann Biomed Eng 36:1281-1290.
10. Di Francia M, Barbier D, Mege JL, Orehek J. 1994. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455.
11. Gosker HR, Langen RC, Bracke KR, Joos GF, Brusselle GG, Steele C, Ward KA, Wouters EF, Schols AM. 2008. Extrapulmonary manifestations of COPD in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol 40: 710-716.
12. Gosker H, Remels A, Sliwinski P, Polkey M, Galdiz J, Wouters E, Langen R, Schols A. 2009. Altered body composition and muscle anabolic, catabolic and metabolic gene expression in COPD patients with elevated skeletal muscle inflammation. Am J Respir Crit Care Med 179:A4200.
13. Handschin C, Chin S, Li P, Liu F, Maratos-Flier E, Lebrasseur NK, Yan Z, Spiegelman BM. 2007. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1 alpha muscle-specific knock-out animals. J Biol Chem 282:30014-30021.
14. Hansen MJ, Gualano RC, Bozinovski S, Vlahos R, Anderson GP. 2006. Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease). Pharmacol Ther 109:162-172.
15. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004.
16. Jobin J, Maltais F, Doyon JF, LeBlanc P, Simard PM, Simard AA, Simard C. 1998. Chronic obstructive pulmonary disease: Capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 18:432-437.
17. Kohn TA, Myburgh KH. 2006. Electrophoretic separation of human skeletal muscle myosin heavy chain isoforms: The importance of reducing agents. J Physiol Sci 56:355-360.
18. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. 2006. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 35:689-696.
19. Leick L, Hellsten Y, Fentz J, Lyngby SS, Wojtaszewski JF, Hidalgo J, Pilegaard H. 2009. PGC-1{alpha}mediates exercise-induced skeletal muscle VEGF expression inmice. Am J Physiol Endocrinol Metab 297: E92-E103.
20. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. 2002. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801.
21. Maltais F, Jobin J, Sullivan MJ, Bernard S, Whittom F, Killian KJ, Desmeules M, Belanger M, LeBlanc P. 1998. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol 84:1573-1580.
22. Mizunoya W, Wakamatsu J, Tatsumi R, Ikeuchi Y. 2008. Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. Anal Biochem 377:111-113.
23. Mrazkova O, Grim M, Carlson BM. 1986. Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am J Anat 177:141-148.
24. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555.
25. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez de Suso JM, Vilaro J, Barbera JA, Polo MF, Argiles JM, Fernandez-Checa JC, Roca J. 2001. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164: 1114-1118.
26. Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM. 2007. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J 30: 245-252.
27. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM. 2006. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103: 16260-16265.
28. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. 1996. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51: 819-824.
29. Schols AM, Slangen J, Volovics L, Wouters EF. 1998. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1791-1797.
30. Spangenburg EE, Booth FW. 2003. Molecular regulation of individual skeletal muscle fibre types. Acta Physiol Scand 178: 413-424.
31. Srere PA. 1969. Citrate synthase. Methods Enzymol 13: 3-5.
32. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. 2000. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1179-1184.
33. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD. 2004. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18: 63-69.
34. Tisdale MJ. 2009. Mechanisms of cancer cachexia. Physiol Rev 89: 381-410.
35. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. 1998. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 30: 1467-1474.
36. Wright JL, Churg A. 1990. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. Am Rev Respir Dis 142: 1422-1428.
37. Wuyam B, Payen JF, Levy P, Bensaidane H, Reutenauer H, Le Bas JF, Benabid AL. 1992. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 5: 157-162.